about
PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion.Aberrant overexpression of the cell polarity module scribble in human cancerMitochondrial Akt Regulation of Hypoxic Tumor ReprogrammingA neuronal network of mitochondrial dynamics regulates metastasis.Carcinosarcoma of the colon: report of a case with morphological, ultrastructural and molecular analysisInhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors.Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue.A new mouse avatar model of non-small cell lung cancer.miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression.Deregulation of MiR-34b/Sox2 Predicts Prostate Cancer Progression.The Contrasting Role of p16Ink4A Patterns of Expression in Neuroendocrine and Non-Neuroendocrine Lung Tumors: A Comprehensive Analysis with Clinicopathologic and Molecular CorrelationsAdaptive mitochondrial reprogramming and resistance to PI3K therapy.The Mitochondrial Unfoldase-Peptidase Complex ClpXP Controls Bioenergetics Stress and Metastasis.Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer.Regulation of lung cancer metastasis by Klf4-Numb-like signalingmiR-494-3p is a novel tumor driver of lung carcinogenesis.Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors.MicroRNA deregulation in parathyroid tumours suggests an embryonic signature.Epigenetic alterations in cancer and personalized cancer treatment.Epigenetic alterations in human parathyroid tumors.Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model.miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo.MicroRNAs in parathyroid physiopathology.Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells.The oncofetal protein IMP3: a novel grading tool and predictor of poor clinical outcome in human gliomas.Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study.MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma.Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors.Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas.microRNA profiles in coeliac patients distinguish different clinical phenotypes and are modulated by gliadin peptides in primary duodenal fibroblasts.IMP3 expression in NSCLC brain metastases demonstrates its role as a prognostic factor in non-neuroendocrine phenotypes.Expression, function, and regulation of the embryonic transcription factor TBX1 in parathyroid tumors.Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models.Filamin A is reduced and contributes to the CASR sensitivity in human parathyroid tumors.Role of Strain Rate in the Pathogenesis of Ventilator-Induced Lung Edema.Expression of C19MC miRNAs in HCC associates with stem-cell features and the cancer-testis genes signature.MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state.Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues.MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.
P50
Q27324467-957EDFF0-EEE8-4AAB-B408-9012719294E0Q28236961-9CF18B58-4593-47AF-A691-8ECE94AE574DQ28771755-379B4350-F07F-469A-9347-89107D059804Q30833071-80B66E1A-D8F7-4C6D-8597-A2A84AC3A7D2Q33249923-41AA7B6E-8B81-4A76-9462-A91152B08ED5Q33435646-C01DCB2C-DAF0-4346-B2AB-E975FAA945DBQ33827053-76DED638-4D4F-4D0C-AA07-12F08C3B41C6Q35013770-019687CB-B2A7-4B46-AB84-46F2501DCDCFQ35141122-58574950-AE38-4945-A8A3-0E2ED2179BB9Q35656084-87A2CEA9-A989-4F71-8759-DE49E94D4421Q35672901-6643027D-BF3F-4A58-A64A-B7AC9C21847AQ35870560-DD4AC2D1-9612-44EE-B716-E6EF91DCCEB5Q36047440-8B9F6D2F-7806-4BB9-BF92-6134F632E774Q36070569-D4366BC7-3E8A-4C23-A920-686038E56C57Q36963631-B6F4ED74-4498-4A4F-A4BA-5C17F0021C0AQ36963728-2DDF0ECD-4467-4E69-99CC-6D8A83BE8001Q37702495-E0565C0B-8EBB-4066-9632-370F32C8CD72Q37706060-F6547BC0-0CA0-46B5-9D4B-A8B0EC4FA4B5Q38313735-F9A437EB-FE0B-4D0D-B927-8A0B305B8C23Q38319591-C8408C27-2A47-4497-86A6-B2EAD0CDAC71Q38365723-72EA4198-A723-4ABA-A861-B9B81B188219Q38894617-66A4682E-964A-4490-906E-F530F3AF6C25Q39023938-01A6AAA7-55ED-4F02-BAF8-ACFF94485485Q39212262-F6D24B45-088D-4C15-A6F1-18E992F2F6DFQ40473497-07D2C0B8-13CD-4A28-9FA9-B087D22B9170Q41393365-49240E0B-C4EF-4002-9215-546D6E8C5261Q41759513-307EC36F-9E2F-4EEB-864B-42ACCD36D640Q42213358-445AB352-2D01-49A3-919F-0D9E5D6E2B55Q42504723-27A79A5A-10DA-429B-B307-B5D1F160259FQ43972235-76435075-D601-49D4-80D5-5AF50DC6AD2BQ44236750-F3523B78-3638-406B-9A85-ADBF43722832Q47325224-9BE239B6-378B-4DCE-B864-E49D89CBF958Q47664476-E4FD01B9-5A96-42F3-9817-E191A3DFA676Q47852873-24BFFFB3-7A1C-49CF-8C99-9EB38228AD53Q51312110-7E4B6183-CB02-4856-BDB6-B9395AEF0E26Q51534375-204A870E-2050-4C2C-92FB-92F73089D45DQ52576991-27D04D9A-41A9-4761-94D1-5B7034899C27Q52727524-B741D389-DFA0-4BCE-A001-A1751E36CB92Q53004454-B49E6240-7E62-4DD4-8BE5-33151C38166CQ53033550-CFCF427B-48B1-427F-B2B2-BDB99C1B0D04
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Valentina Vaira
@ast
Valentina Vaira
@en
Valentina Vaira
@es
Valentina Vaira
@nl
Valentina Vaira
@sl
type
label
Valentina Vaira
@ast
Valentina Vaira
@en
Valentina Vaira
@es
Valentina Vaira
@nl
Valentina Vaira
@sl
prefLabel
Valentina Vaira
@ast
Valentina Vaira
@en
Valentina Vaira
@es
Valentina Vaira
@nl
Valentina Vaira
@sl
P1053
K-6499-2016
P106
P1153
14629570900
P21
P31
P3829
P496
0000-0003-4416-6216